GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab
Status:
Recruiting
Trial end date:
2024-11-25
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the safety and the clinical activities of NP137 when
combined with pembrolizumab and/or chemotherapies in patients with advanced/metastatic
gynecological cancers (2 types: endometrial carcinoma and cervix carcinoma).